Cyr61 Participates in the Pathogenesis of Acute Lymphoblastic Leukemia by Enhancing Cellular Survival via the AKT/NF-κB Signaling Pathway

Scientific Reports - United Kingdom
doi 10.1038/srep34018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cyr61 Decreases Cytarabine Chemosensitivity in Acute Lymphoblastic Leukemia Cells via NF-κB Pathway Activation

International Journal of Molecular Medicine
MedicineGenetics
2018English

Hepatitis B Virus Upregulates Cellular Inhibitor of Apoptosis Protein�2 Expression via the PI3K/AKT/NF‑κB Signaling Pathway in Liver Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Cyr61 Regulates the Chemosensitivity of Chronic Myeloid Leukemia to Imatinib Mesylate Through the NF ‐κB/Bcl‐2 Pathway

Cancer Science
Cancer ResearchMedicineOncology
2019English

Neuron-Derived FGF10 Ameliorates Cerebral Ischemia Injury via Inhibiting NF-κB-dependent Neuroinflammation and Activating PI3K/Akt Survival Signaling Pathway in Mice

Scientific Reports
Multidisciplinary
2016English

Cabozantinib Induces PUMA-dependent Apoptosis in Colon Cancer Cells via AKT/GSK-3β/NF-κB Signaling Pathway

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Protective Effect of Hydroxysafflor Yellow a Against Acute Kidney Injury via the TLR4/NF-κB Signaling Pathway

Scientific Reports
Multidisciplinary
2018English

DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-κB Pathway in Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Non-Canonical NF-κB Signaling Pathway

Cell Research
Cell BiologyMolecular Biology
2010English

Oroxylin-A Rescues LPS-Induced Acute Lung Injury via Regulation of NF-κB Signaling Pathway in Rodents

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy